197 related articles for article (PubMed ID: 19401508)
1. Dr Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis.
Ohry A
J Med Biogr; 2009 May; 17(2):73-4. PubMed ID: 19401508
[TBL] [Abstract][Full Text] [Related]
2. Mary Broadfoot Walker (1888-1974).
Johnston JD
J Neurol; 2007 Sep; 254(9):1306-7. PubMed ID: 18000738
[No Abstract] [Full Text] [Related]
3. Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology.
Keesey JC
Neurology; 1998 Nov; 51(5):1433-9. PubMed ID: 9818874
[TBL] [Abstract][Full Text] [Related]
4. "Crisis" in myasthenia gravis: an historical perspective.
Keesey JC
Muscle Nerve; 2002 Jul; 26(1):1-3. PubMed ID: 12115943
[No Abstract] [Full Text] [Related]
5. Mary Broadfoot Walker: 83 years since a historical discovery.
Carvalho VM; Nogueira EAG; Rosa GR; Fragoso YD
Arq Neuropsiquiatr; 2017 Nov; 75(11):825-826. PubMed ID: 29236828
[TBL] [Abstract][Full Text] [Related]
6. The Mary Walker effect: Mary Broadfoot Walker.
McCarter SJ; Burkholder DB; Klaas JP; Martinez-Thompson JM; Boes CJ
J R Coll Physicians Edinb; 2019 Sep; 49(3):255-259. PubMed ID: 31497797
[TBL] [Abstract][Full Text] [Related]
7. Mary Broadfoot Walker (1888-1974): a historic discovery in myasthenia gravis.
Pearce JM
Eur Neurol; 2005; 53(1):51-3. PubMed ID: 15746548
[TBL] [Abstract][Full Text] [Related]
8. Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis.
Keeney AH; Keeney VT
Doc Ophthalmol; 1997; 93(1-2):125-34. PubMed ID: 9476610
[TBL] [Abstract][Full Text] [Related]
9. The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.
Johnston JD
J Hist Neurosci; 2005 Jun; 14(2):121-37. PubMed ID: 16019657
[TBL] [Abstract][Full Text] [Related]
10. The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis.
Katz NK; Barohn RJ
Neuropharmacology; 2021 Jan; 182():108303. PubMed ID: 32918950
[TBL] [Abstract][Full Text] [Related]
11. The history of myasthenia gravis.
Pascuzzi RM
Neurol Clin; 1994 May; 12(2):231-42. PubMed ID: 8041339
[TBL] [Abstract][Full Text] [Related]
12. The miracle at St Alfege's: seventy years on.
Lee MR
J R Soc Med; 2007 Feb; 100(2):108-9. PubMed ID: 17277286
[No Abstract] [Full Text] [Related]
13. [Opus posthumous].
Kotsias BA
Medicina (B Aires); 2017; 77(5):440-441. PubMed ID: 29044026
[No Abstract] [Full Text] [Related]
14. [Current treatment of myasthenia gravis].
de Assis JL
Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
[No Abstract] [Full Text] [Related]
15. Myasthenia gravis and glycopyrrolate.
Marcus E; Wayne F
S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
[No Abstract] [Full Text] [Related]
16. Post-varicella myasthenia gravis.
Saha A; Batra P; Vilhekar KY; Chaturvedi P
Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
[TBL] [Abstract][Full Text] [Related]
17. [Triaminopteridine in the therapy of myasthenia gravis].
Mansoldo G; Battocchia A; De Candia O
Minerva Med; 1968 Apr; 59(33):1936-9. PubMed ID: 5653968
[No Abstract] [Full Text] [Related]
18. Teaching neuroimages: reversible ectropion in myasthenia gravis.
Chang GY; Solé G; Ferrer X
Neurology; 2010 Apr; 74(15):1239; author reply 1239. PubMed ID: 20385900
[No Abstract] [Full Text] [Related]
19. Breaking Down Myasthenic Crisis.
Wijdicks EFM
Neurocrit Care; 2020 Jun; 32(3):875-879. PubMed ID: 31981022
[No Abstract] [Full Text] [Related]
20. [Historical view on the development of knowledge about myasthenia gravis. (Introduction to a symposium)].
Hausmanowa-Petrusewicz I
Neurol Neurochir Pol; 1970; 4(3):261-4. PubMed ID: 4917026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
